| Page 8 | Kisaco Research

This session provides the unique opportunity to listen to, and engage with, some of the most innovative AI Drug Discovery and Development start-ups globally. Focusing exclusively on early-stage funding, six startups picked by our esteemed selection committee will take to the stage in front of 100+ potential partners. Through a series of rapid-fire presentations, these pioneers will demonstrate their vision of the future of drug discovery, and how their product, technology, or service fits into it.

Showcasing generative models that craft hyper‑personalized outreach messages and informed consent materials, driving up engagement rates and shaving weeks off recruitment timelines.
Discover how ML‑driven forecasts for recruitment rates and optimized site selection translate into faster first‑patient‑in and lower screen‑fail/dropout rates, saving you both time and budget.